CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis

CPVL (carboxypeptidase, vitellogenic-like) is a serine carboxypeptidase that was first characterized in human macrophages. However, the function of CPVL remains unclear in a variety of tumors. The quantitative PCR (qPCR), Western blotting, and IHC assays were utilized to measure the CPVL expression....

Full description

Bibliographic Details
Main Authors: Hui Yang, Xiaocen Liu, Xiaolong Zhu, Xueqin Li, Lan Jiang, Min Zhong, Mengying Zhang, Tianbing Chen, Mingzhe Ma, Xiuming Liang, Kun Lv
Format: Article
Language:English
Published: American Society for Clinical investigation 2021-12-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.146362
_version_ 1811227221697757184
author Hui Yang
Xiaocen Liu
Xiaolong Zhu
Xueqin Li
Lan Jiang
Min Zhong
Mengying Zhang
Tianbing Chen
Mingzhe Ma
Xiuming Liang
Kun Lv
author_facet Hui Yang
Xiaocen Liu
Xiaolong Zhu
Xueqin Li
Lan Jiang
Min Zhong
Mengying Zhang
Tianbing Chen
Mingzhe Ma
Xiuming Liang
Kun Lv
author_sort Hui Yang
collection DOAJ
description CPVL (carboxypeptidase, vitellogenic-like) is a serine carboxypeptidase that was first characterized in human macrophages. However, the function of CPVL remains unclear in a variety of tumors. The quantitative PCR (qPCR), Western blotting, and IHC assays were utilized to measure the CPVL expression. CPVL was significantly upregulated in glioma cells and tissues compared with normal cells and tissues, respectively. Moreover, high CPVL expression was correlated with advanced clinical grade and poor prognosis. Silencing of CPVL promoted glioma cell apoptosis, and it inhibited cell proliferation and tumorigenicity in vitro and in vivo. Ingenuity Pathway Analysis (IPA) demonstrated that CPVL silencing activated the IFN-γ/STAT1 signaling pathway, thereby inducing glioma cell apoptosis. Mechanistically, immunopurification, mass spectrometry, IP, and glutathione S-transferase (GST) pull-down experiments elucidated that CPVL physically interacts with Bruton’s tyrosine kinase (BTK) and downregulates the STAT1 phosphorylation through promoting p300-mediated STAT1 acetylation. Our findings reveal the crucial role of CPVL in promoting the progression of glioma through suppressing STAT1 phosphorylation. CPVL might serve as a potential prognostic biomarker and therapeutic target for the treatment of glioma.
first_indexed 2024-04-12T09:37:55Z
format Article
id doaj.art-79f67ce47a354e2ba31d39d16b9858b0
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-04-12T09:37:55Z
publishDate 2021-12-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-79f67ce47a354e2ba31d39d16b9858b02022-12-22T03:38:10ZengAmerican Society for Clinical investigationJCI Insight2379-37082021-12-01624CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axisHui YangXiaocen LiuXiaolong ZhuXueqin LiLan JiangMin ZhongMengying ZhangTianbing ChenMingzhe MaXiuming LiangKun LvCPVL (carboxypeptidase, vitellogenic-like) is a serine carboxypeptidase that was first characterized in human macrophages. However, the function of CPVL remains unclear in a variety of tumors. The quantitative PCR (qPCR), Western blotting, and IHC assays were utilized to measure the CPVL expression. CPVL was significantly upregulated in glioma cells and tissues compared with normal cells and tissues, respectively. Moreover, high CPVL expression was correlated with advanced clinical grade and poor prognosis. Silencing of CPVL promoted glioma cell apoptosis, and it inhibited cell proliferation and tumorigenicity in vitro and in vivo. Ingenuity Pathway Analysis (IPA) demonstrated that CPVL silencing activated the IFN-γ/STAT1 signaling pathway, thereby inducing glioma cell apoptosis. Mechanistically, immunopurification, mass spectrometry, IP, and glutathione S-transferase (GST) pull-down experiments elucidated that CPVL physically interacts with Bruton’s tyrosine kinase (BTK) and downregulates the STAT1 phosphorylation through promoting p300-mediated STAT1 acetylation. Our findings reveal the crucial role of CPVL in promoting the progression of glioma through suppressing STAT1 phosphorylation. CPVL might serve as a potential prognostic biomarker and therapeutic target for the treatment of glioma.https://doi.org/10.1172/jci.insight.146362Oncology
spellingShingle Hui Yang
Xiaocen Liu
Xiaolong Zhu
Xueqin Li
Lan Jiang
Min Zhong
Mengying Zhang
Tianbing Chen
Mingzhe Ma
Xiuming Liang
Kun Lv
CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis
JCI Insight
Oncology
title CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis
title_full CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis
title_fullStr CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis
title_full_unstemmed CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis
title_short CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis
title_sort cpvl promotes glioma progression via stat1 pathway inhibition through interactions with the btk p300 axis
topic Oncology
url https://doi.org/10.1172/jci.insight.146362
work_keys_str_mv AT huiyang cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT xiaocenliu cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT xiaolongzhu cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT xueqinli cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT lanjiang cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT minzhong cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT mengyingzhang cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT tianbingchen cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT mingzhema cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT xiumingliang cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis
AT kunlv cpvlpromotesgliomaprogressionviastat1pathwayinhibitionthroughinteractionswiththebtkp300axis